Mirae Asset Global Etfs Holdings Ltd. Protalix Bio Therapeutics, Inc. Put Options Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding PLX
# of Institutions
63Shares Held
5.83MCall Options Held
103KPut Options Held
4.6K-
Israel Englander Millennium Management LLC | New York, Ny811KShares$940,9450.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny805KShares$933,3350.0% of portfolio
-
Goldman Sachs Group Inc New York, NY462KShares$535,8710.0% of portfolio
-
Gsa Capital Partners LLP London, X0435KShares$504,8470.03% of portfolio
-
Northern Trust Corp Chicago, IL423KShares$490,9270.0% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $57.7M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...